Thanks, interesting we already use DB-TACE with with dox or oxaliplatin and 5-fluorouracil followed by Lipiodol chemoembolization.
This is a retrospective study
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385545/
Not sure if there have been any studies like this you mention that is prospective and randomised.
But will be interesting to see what happens if the gold standard shifts to SIRT.
Would that make this trail obsolete before it's really got started?
Boston Scientific aims to localize chemotherapy drugs to tackle liver cancer, page-2
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.27M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.5¢ | $292.8K | 1.630M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 7394560 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 1260654 | 10 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| SRX (ASX) Chart |